European Journal of Nuclear Medicine and Molecular Imaging
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.6 | Q1 | 94.9% | 2.167 | Q1 | 95.9% |
| 2024 | 7.6 | Q1 | 95.8% | 2.392 | Q1 | 96.6% |
| 2023 | 8.6 | Q1 | 96.5% | 2.280 | Q1 | 96.5% |
| 2022 | 9.1 | Q1 | 96.5% | 2.100 | Q1 | 96.1% |
| 2021 | 10.1 | Q1 | 96.4% | 2.003 | Q1 | 95.9% |
| 2020 | — | — | 2.313 | Q1 | 96.5% | |
| 2019 | — | — | 2.117 | Q1 | 96.1% | |
| 2018 | — | — | 2.421 | Q1 | 96.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1619-7070
ISSN
1619-7089
region
Western Europe
coverage
1996-1997, 1999, 2001-2026